Cargando…

Correction: ShRNA-Targeted COMMD7 Suppresses Hepatocellular Carcinoma Growth

Detalles Bibliográficos
Autores principales:	Zheng, Lu, Liang, Ping, Li, Jing, Huang, Xiao-bing, Liu, Shi-cheng, Zhao, Hong-zhi, Han, Ke-qiang, Wang, Zheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2019
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6422287/ https://www.ncbi.nlm.nih.gov/pubmed/30883605 http://dx.doi.org/10.1371/journal.pone.0214259

Ejemplares similares

ShRNA-Targeted COMMD7 Suppresses Hepatocellular Carcinoma Growth
por: Zheng, Lu, et al.
Publicado: (2012)

ShRNA-Targeted Centromere Protein A Inhibits Hepatocellular Carcinoma Growth
por: Li, Yongmei, et al.
Publicado: (2011)

COMMD7 is correlated with a novel NF-κB positive feedback loop in hepatocellular carcinoma
por: Zheng, Lu, et al.
Publicado: (2016)

COMMD7 Regulates NF-κB Signaling Pathway in Hepatocellular Carcinoma Stem-like Cells
por: Zheng, Lu, et al.
Publicado: (2018)

Correction: Adventitial Delivery of Lentivirus-shRNA-ADAMTS-1 Reduces Venous Stenosis Formation in Arteriovenous Fistula
Publicado: (2014)

Construction of shRNA lentiviral vector
por: Song, Hong, et al.
Publicado: (2010)

Suppression of Cancer Progression by MGAT1 shRNA Knockdown
por: Beheshti Zavareh, Reza, et al.
Publicado: (2012)

Correction: Synthetic tetracycline-controllable shRNA targeting long non-coding RNA HOXD-AS1 inhibits the progression of bladder cancer
por: Li, Jianfa, et al.
Publicado: (2023)

ShRNA knock‐down of CXCR7 inhibits tumour invasion and metastasis in hepatocellular carcinoma after transcatheter arterial chemoembolization
por: Zhao, Zhong‐Wei, et al.
Publicado: (2017)

Correction: shRNA-Based Screen Identifies Endocytic Recycling Pathway Components That Act as Genetic Modifiers of Alpha-Synuclein Aggregation, Secretion and Toxicity
Publicado: (2016)

Optimized PCR Conditions and Increased shRNA Fold Representation Improve Reproducibility of Pooled shRNA Screens
por: Strezoska, Žaklina, et al.
Publicado: (2012)

LncRNA HULC shRNA disinhibits miR-377-5p to suppress the growth and invasion of hepatocellular carcinoma in vitro and hepatocarcinogenesis in vivo
por: Yan, Chunxiao, et al.
Publicado: (2020)

Irreversible electroporation-mediated shRNA knockdown of the HPV18 E6 gene suppresses cervical cancer growth in vitro and in vivo
por: Wang, Zhi-Liang, et al.
Publicado: (2017)

Correction: Defining COMMD4 as an anti-cancer therapeutic target and prognostic factor in non-small cell lung cancer
por: Suraweera, Amila, et al.
Publicado: (2021)

Transcriptional analysis of the expression, prognostic value and immune infiltration activities of the COMMD protein family in hepatocellular carcinoma
por: Wang, Xiaobo, et al.
Publicado: (2021)

ANT2 suppression by shRNA restores miR-636 expression, thereby downregulating Ras and inhibiting tumorigenesis of hepatocellular carcinoma
por: Jang, Ji-Young, et al.
Publicado: (2013)

Suppression of pancreatic cancer growth and metastasis by HMP19 identified through genome‐wide shRNA screen
por: Kurahara, Hiroshi, et al.
Publicado: (2016)

Investigating the Association between COMMD3 Expression and the Prognosis of Hepatocellular Carcinoma
por: Cheng, Wei, et al.
Publicado: (2022)

shRNA target prediction informed by comprehensive enquiry (SPICE): a supporting system for high-throughput screening of shRNA library
por: Kamatuka, Kenta, et al.
Publicado: (2016)

Correction: Transgenic shRNA pigs reduce susceptibility to foot and mouth disease virus infection
por: Hu, Shengwei, et al.
Publicado: (2016)

Adenovirus vectors lacking virus-associated RNA expression enhance shRNA activity to suppress hepatitis C virus replication
por: Pei, Zheng, et al.
Publicado: (2013)

Delivery of Therapeutic AGT shRNA by PEG-Bu for Hypertension Therapy
por: Wang, Yu-Qiang, et al.
Publicado: (2013)

Self‐Activated Cascade‐Responsive Sorafenib and USP22 shRNA Co‐Delivery System for Synergetic Hepatocellular Carcinoma Therapy
por: Xu, Shengjun, et al.
Publicado: (2021)

The influence of survivin shRNA on the cell cycle and the invasion of SW480 cells of colorectal carcinoma
por: Zhonghong, Liu, et al.
Publicado: (2008)

Silencing of SOX12 by shRNA suppresses migration, invasion and proliferation of breast cancer cells
por: Ding, Hanzhi, et al.
Publicado: (2016)

Suppression of IL-6 Gene by shRNA Augments Gemcitabine Chemosensitization in Pancreatic Adenocarcinoma Cells
por: Xing, Hai-Bo, et al.
Publicado: (2018)

Silence of MCL-1 upstream signaling by shRNA abrogates multiple myeloma growth
por: Wang, Mengchang, et al.
Publicado: (2014)

High expression of COMMD7 is an adverse prognostic factor in acute myeloid leukemia
por: Li, Kongfei, et al.
Publicado: (2021)

Protamine nanoparticles for improving shRNA-mediated anti-cancer effects
por: Liu, Ming, et al.
Publicado: (2015)

Adapted Resistance to the Knockdown Effect of shRNA-Derived Srsf3 siRNAs in Mouse Littermates
por: Ajiro, Masahiko, et al.
Publicado: (2015)

Growth inhibition and chemo-radiosensitization of esophageal squamous cell carcinoma by survivin-shRNA lentivirus transfection
por: Zhou, Changlin, et al.
Publicado: (2018)

Cationic vesicles for efficient shRNA transfection in the MCF-7 breast cancer cell line
por: Mokhtary, Pardis, et al.
Publicado: (2018)

shRNA-armed conditionally replicative adenoviruses: a promising approach for cancer therapy
por: Zhang, Jie, et al.
Publicado: (2016)

Silencing of ENO1 by shRNA Inhibits the Proliferation of Gastric Cancer Cells
por: Qiao, Hui, et al.
Publicado: (2018)

shRNA-Mediated Silencing of Y-Box Binding Protein-1 (YB-1) Suppresses Growth of Neuroblastoma Cell SH-SY5Y In Vitro and In Vivo
por: Wang, Hong, et al.
Publicado: (2015)

Optimization and characterization of tRNA-shRNA expression constructs
por: Scherer, Lisa J., et al.
Publicado: (2007)

Design and cloning strategies for constructing shRNA expression vectors
por: McIntyre, Glen J, et al.
Publicado: (2006)

The effects of stem length and core placement on shRNA activity
por: Mcintyre, Glen J, et al.
Publicado: (2011)

Optimization of Duplex Stability and Terminal Asymmetry for shRNA Design
por: Matveeva, Olga V., et al.
Publicado: (2010)

Energy profile and secondary structure impact shRNA efficacy
por: Zhou, Hong, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_j70qca24lokisjer17vuue3uue